Form 4: ANI Pharmaceuticals Executive Exercises Stock Options and Sells Shares
SEC Form 4
James G. Marken, SVP of Operations & Product Development at ANI Pharmaceuticals, exercised stock options and sold shares on June 7, 2024, while also correcting a previous reporting error.
Summary
- On June 7, 2024, James G. Marken, SVP of Operations & Product Development at ANI Pharmaceuticals, exercised stock options to acquire 7,250 shares at $49.51 and 5,300 shares at $57.06.
- Marken also disposed of 11,087 shares to cover tax obligations at a weighted average price of $67.70.
- Following these transactions, Marken directly owns 117,829 shares of ANI Pharmaceuticals.
- An amendment was made to correct an administrative error in a previous Form 4 filed on March 9, 2023, regarding the number of shares withheld for taxes, resulting in a net increase of 360 shares beneficially owned.
- The shares were sold in multiple trades at prices ranging from $67.64 to $68.10.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 03/31/2018 | 25% of stock options vested |
| 03/31/2019 | 25% of stock options vested |
| 04/06/2019 | 25% of stock options vested |
| 03/31/2020 | 25% of stock options vested |
| 04/06/2020 | 25% of stock options vested |
| 03/31/2021 | 25% of stock options vested |
| 04/06/2021 | 25% of stock options vested |
| 03/09/2023 | Date of original Form 4 filing with administrative error |
| 04/06/2022 | 25% of stock options vested |
| 06/07/2024 | Date of stock option exercise and share disposal |
| 06/11/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.